--- title: "Arteris is down 52% from its June high, royalties grew 65%, and cash guidance is gone before November 5" description: "A vendor's fair-value model got the credit for Arteris' 52 percent slide, but the operating file tells the real story: royalties compounding at 65 percent, revenue guided flat, quarterly cash guidance withdrawn, and the November 5 print as the first test." publisher: "The Inference" section: "Chips" published: 2026-11-02T14:17:20.586Z modified: 2026-11-02T14:17:20.586Z canonical: https://theinference.org/article/arteris-is-down-52-from-its-june-high-royalties-grew-65-and-cash-guidance-is-gone-before-november-5 language: en keywords: "Semiconductors, Earnings, Guidance, IP Licensing, Chip Design" --- # Arteris is down 52% from its June high, royalties grew 65%, and cash guidance is gone before November 5 > A vendor's fair-value model got the credit for Arteris' 52 percent slide, but the operating file tells the real story: royalties compounding at 65 percent, revenue guided flat, quarterly cash guidance withdrawn, and the November 5 print as the first test. [Arteris](https://theinference.org/markets/companies/arteris), the network-on-chip IP licensor whose technology routes data inside the chips behind AI data centers, fell 52 percent from its June high of $45.33 to $20.59 by late October [1]. Nearly every line written about that slide traced back to [one vendor's valuation model](https://www.investing.com/news/investment-ideas/investingpros-fair-value-spotted-arteris-overvaluation-before-52-drop-93CH-4986912). The operating file behind the drop has gone unread. It contains a business compounding royalties at 65 percent, a Q3 revenue guide that barely moves, and a cash-flow disclosure the company just stopped providing [1][2]. ## Two camps, one stock The bulls hold a royalty story. Trailing-twelve-month variable royalties, payments that follow customers' chips into production, reached $8.6 million, up 65 percent [2]. Remaining performance obligations, contracted revenue not yet recognized, hit $135 million, up 36 percent [2]. Cash and short-term investments stood at $122.1 million at June 30 [2]. The sceptics read the same quarter differently: Q3 revenue is guided to $24.0 to $25.0 million, a midpoint about 2 percent above the $24.1 million just printed, and [quarterly free cash flow guidance has been discontinued](https://kalkine.com.au/stock-analysis/technology/why-is-arteris-guiding-to-higher-royalties) [2]. That means design wins are on the contract ledger but the chips are not yet shipping. The market has already voted with a 52 percent drawdown [1]. *Chart: **Revenue nearly doubled in two years while cash flow swung from -$7.4M to +$8.6M** Column chart of Arteris quarterly revenue and free cash flow from Q3 2024 through Q2 2026, revenue rising from 14.7 to 24.1 million dollars while free cash flow swings between negative 7.4 and positive 8.6 million dollars.* *Arteris quarterly revenue and free cash flow, USD millions, from SEC filings, Q3 2024 to Q2 2026. The Q1 2026 cash outflow includes about $3 million of Cycuity acquisition consideration and fees. [5]* ## What the operating file shows Second-quarter revenue was $24.1 million, up 46 percent from $16.5 million a year earlier, and the year-on-year growth rate accelerated four quarters running, from 18.3 percent through 30 percent, 38.7 percent and 46.2 percent [2][5]. The sequential path was not a straight climb; revenue dipped slightly from $16.53 million in Q1 2025 to $16.5 million in Q2 2025 [5]. *Chart: **Revenue growth accelerated for four straight quarters before the November 5 print** Line chart of Arteris quarterly revenue growth year on year, rising from 10.8 percent in Q3 2024 to 46.2 percent in Q2 2026, with a dip to 13.2 percent in Q2 2025.* *Year-on-year revenue growth by quarter, percent, from Arteris' SEC filings, Q3 2024 to Q2 2026. [5]* Losses widened too: the GAAP operating loss reached $13.9 million against $8.2 million a year before, and first-half free cash flow was just $1.3 million despite a strong $8.6 million second quarter [2]. The swings have a named cause: the $7.36 million negative free cash flow in Q1 2026 included roughly $3 million of Cycuity acquisition consideration and fees [4]. Management flagged the rest: larger deal sizes create quarter-to-quarter cash flow swings, so it guides annually now [4]. The full-year range, $5.0 to $9.0 million of free cash flow on $95.0 to $98.0 million of revenue, is the only yardstick left [2]. ## The prints that cut both ways Three signals inside the quarter point in opposite directions. Insider sales by the CEO, CFO and other executives totaled over $15 million, per one write-up; that source also carries an internally inconsistent revenue figure for Q2, so the sales total deserves its own check against Form 4 filings, the SEC disclosures that record insider trades, before any trade rests on it [1]. Chief executive [K. Charles Janac](https://theinference.org/markets/people/k-charles-janac) told investors that two-thirds of customer engagements are into AI chips, and that data center design cycles "rise quicker and they also die quicker" [4]. Chief financial officer Nicholas Hawkins gave the timing answer in the same session: hyperscaler royalties take two to three years to flow through [4]. Hawkins, who built the guidance record, retires August 31 [4]. ## The verdict arrives Thursday [Q3 results land November 5](https://www.manilatimes.net/2026/10/21/tmt-newswire/globenewswire/arteris-to-announce-financial-results-for-the-third-quarter-2026-on-thursday-november-5-2026/2450647), the first print since quarterly cash guidance was withdrawn [3]. Watch three lines: revenue inside the $24.0 to $25.0 million range, the non-GAAP operating loss against the guided $1.0 to $3.0 million, and royalty growth [2]. If royalties keep compounding while revenue sits flat, the compounders were right and the market mispriced a timing gap. If royalties stall too, the design wins were recorded on contracts rather than collected from shipped chips, and $122.1 million of cash is the only floor left [2]. Either answer arrives in one print. ## Takeaway Arteris' 52 percent slide is usually credited to a vendor's valuation model, but the operating file shows royalties up 65 percent against flat revenue guidance and withdrawn quarterly cash guidance; the November 5 print decides which reading was right. ## Sources 1. [Investing.com, InvestingPro's Fair Value spotted Arteris overvaluation before 52% drop, 30 October 2026](https://www.investing.com/news/investment-ideas/investingpros-fair-value-spotted-arteris-overvaluation-before-52-drop-93CH-4986912) 2. [Kalkine, Why is Arteris guiding to higher royalties?, 28 October 2026](https://kalkine.com.au/stock-analysis/technology/why-is-arteris-guiding-to-higher-royalties) 3. [The Manila Times (GlobeNewswire), Arteris to Announce Financial Results for the Third Quarter 2026 on Thursday, November 5, 2026, 21 October 2026](https://www.manilatimes.net/2026/10/21/tmt-newswire/globenewswire/arteris-to-announce-financial-results-for-the-third-quarter-2026-on-thursday-november-5-2026/2450647) 4. [Seeking Alpha via MSN, Arteris raises FY 2026 revenue outlook while targeting non-GAAP operating profit as early as Q4, 12 May 2026](https://www.msn.com/en-us/money/general/arteris-raises-fy-2026-revenue-outlook-to-91m-95m-while-targeting-non-gaap-operating-profit-as-early-as-q4/ar-AA2326sE) 5. [Arteris quarterly figures from SEC filings, via company_series, retrieved 2 November 2026](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001667011) --- Arteris is down 52% from its June high, royalties grew 65%, and cash guidance is gone before November 5 — The Inference. Canonical: https://theinference.org/article/arteris-is-down-52-from-its-june-high-royalties-grew-65-and-cash-guidance-is-gone-before-november-5